Related by context. All words. (Click for frequent words.) 72 ATIR 69 ATIR ™ 66 BrachySil TM 65 Azedra 65 rALLy clinical trial 64 elacytarabine 64 Civacir 64 mismatched bone marrow 64 alvespimycin 64 IMA# 64 transplantation HCT 64 SEPET TM 64 DEEP AF 63 HQK 63 deferiprone 63 YONDELIS 63 Myocet 63 Sym# 63 relapsed multiple myeloma 62 allogeneic stem cell 62 TRO# 62 EOquin TM 62 sunitinib malate 62 OHR/AVR# 62 riociguat 62 phase IIb trial 62 Pivotal Trial 62 DU #b 62 hematopoietic stem cell 62 HuMax EGFr 62 vidofludimus 62 ospemifene 62 Archexin 62 allogeneic HSCT 62 Phase #/#a 61 Phase #b/#a clinical 61 Aplidin 61 small molecule activators 61 Litx 61 ganetespib 61 Personalized Immunotherapy 61 acyclovir Lauriad R 61 VDAs 61 therapeutic monoclonal antibody 61 Manja Bouman CEO 61 tanespimycin 61 phase IIb clinical 61 LHRH antagonists 61 forodesine 61 invasive candidiasis 61 Icatibant 61 HuMax CD4 61 FOLOTYN ® 61 calcineurin inhibitors 61 GEM OS2 61 hematopoietic cell 61 corticosteroid dexamethasone 61 MGd 61 Mipomersen 61 PRT# 61 acyclovir Lauriad ® 61 Cloretazine ® 61 TAXUS TM 61 Augment TM 60 allogeneic bone marrow 60 antifungal therapy 60 VITAL Trial 60 bevacizumab Avastin ® 60 transplantation HSCT 60 Islet transplantation 60 DCVax ® Brain 60 trastuzumab DM1 T DM1 60 OMP #R# 60 Factor VIIa 60 Evoltra ® 60 pegfilgrastim 60 TPI ASM8 60 ENMD # 60 OncoVEX 60 Phase IIb clinical trials 60 investigational pan BCR 60 oral prodrug 60 sorafenib tablets 60 Ophena 60 Cleviprex TM clevidipine 60 OncoVEX GM CSF 60 AFRS TM 60 receptor tyrosine kinase inhibitor 60 luliconazole 60 Alocrest 60 biodegradable implant 60 kidney urologic 60 Hematopoietic stem cell 60 PDE4 inhibitor 60 drug ISA# 60 CTAP# Capsules 60 phase IIb 60 Phase #b/#a 60 Vicinium TM 60 therapeutic regimens 60 MYDICAR ® 60 GEM OS1 60 INTERCEPT platelets 60 SNT MC# 60 Trofex 60 Xanafide 60 Phase Ib II 60 oxypurinol 60 docetaxel Taxotere ® 60 Fibrin Pad 60 refractory angina 60 Oral NKTR 60 R sorafenib tablets 60 Allovectin 7 r 60 MabThera rituximab 59 Cloretazine 59 Combo Stent 59 MYDICAR 59 Lixivaptan 59 Dapagliflozin 59 Revimmune 59 targeted radiotherapeutic 59 FVIIa 59 StemEx 59 Cx# [002] 59 Proxinium TM 59 Ketotransdel 59 BAY #-# 59 PI3K/Akt pathway inhibitor 59 DXL# 59 PICSO ® 59 MYCAMINE 59 steroid refractory 59 hereditary deficiency 59 depsipeptide 59 reslizumab 59 including eniluracil ADH 59 Urocidin 59 mertansine 59 ESBA# 59 deforolimus 59 mechanical thrombectomy 59 Rheos System 59 ELACYT 59 investigational monoclonal antibody 59 factor G CSF 59 noninfectious uveitis 59 JAK inhibitor 59 Allovectin 7 59 CRMD# 59 dexanabinol 59 ABSORB trial 59 HepeX B 59 ThermoDox R 59 ocular formulation 59 C1 INH 59 Simulect 59 coronary stenting 59 immunosuppressant drug 59 Voraxaze 59 INCB# [001] 59 Aviptadil 59 oral ridaforolimus 59 HGS# 59 Edwards SAPIEN valve 59 Neulasta ® 59 Optical Biopsy System 59 OZURDEX ® 59 RECOTHROM R 59 terlipressin 59 allogenic 59 ganaxolone 59 AZILECT ® 59 liposomal formulation 59 DermaVir Patch 59 external counterpulsation systems 59 Nanobody ® 59 Triapine R 59 atherosclerosis regression 59 transplant HSCT 59 Mepact 59 gastrointestinal stromal tumors GIST 59 Phase IIIb study 59 Neuradiab 59 R#/MEM # 59 placebo controlled Phase III 59 Soliris eculizumab 59 VNP#M 59 Initiate Clinical Trial 59 Amrubicin 59 BR.# 59 Augment Injectable 59 INT# [002] 59 sorafenib Nexavar 58 PHX# 58 SUTENT ® 58 CBLC# 58 Altastaph 58 Toraymyxin TM 58 Vascugel ® 58 pain palliation 58 GTC recombinant human 58 metastatic neuroendocrine tumors 58 filgrastim 58 lomitapide 58 Allovectin 7 ® 58 Neupogen ® 58 Laquinimod 58 oral deforolimus 58 Phase IIIb clinical 58 BRAF inhibitor 58 ImmuKnow 58 CCX# 58 Pervasis 58 ularitide 58 VAPRISOL 58 immunotherapeutic vaccine 58 candidate TNFerade biologic 58 StemEx R 58 PFO closure 58 Vascular Wrap TM 58 MyVax R 58 INFUSE ® 58 immunosuppressive regimens 58 Granulocyte Colony Stimulating Factor 58 multicenter Phase III 58 PANVAC VF 58 Virulizin ® 58 Phase III Pivotal 58 TLK# 58 CIMZIA ™ 58 GRNVAC1 58 daptomycin 58 PREOS R 58 Panzem R 58 QTinno TM 58 HuMax TAC 58 StaphVAX 58 Nexavar sorafenib 58 DCVax R 58 Allovectin 7 R 58 fibrin sealant 58 metastatic sarcomas 58 refractory chronic lymphocytic 58 oral rivaroxaban 58 candidemia 58 CINQUIL 58 Inhalation Solution 58 OncoGel 58 LEUKINE 58 CINTREDEKIN BESUDOTOX 58 CA9 SCAN 58 bardoxolone 58 Privigen 58 Cetrorelix 58 MAA submission 58 LibiGel ® 58 exemestane Aromasin 58 blood clot dissolver 58 orBec 58 Tacrolimus 58 L BLP# 58 Phase Ib study 58 angiogenesis inhibitor 58 antibody MAb 58 QuadraSphere 58 refractory gout 58 Microplasmin 58 Amigal 58 JAK#/JAK# inhibitor CYT# 58 pharmacokinetic PK study 58 pertuzumab 58 ALN TTR# 58 ruxolitinib 58 HuLuc# 58 Dacogen injection 58 oral antiviral 58 novel oral anticoagulant 58 haematopoietic stem cell 58 Fx #A 58 Prodarsan R 58 platelet inhibitor 58 CD# antibody [001] 58 oral talactoferrin 58 subcutaneous formulation 58 erythropoietic 58 Insegia 58 cathepsin K inhibitor 58 EFAPROXYN 58 allogeneic 58 Neovasc Reducer 58 HepaMate 58 delipidation 58 BrachySil 58 myelofibrosis polycythemia vera 58 cartilage regeneration 58 clevidipine 58 elotuzumab 58 registrational 58 rhThrombin 58 OvaRex R 58 favorable pharmacokinetic profile 58 personalized immunotherapy 58 allogeneic hematopoietic stem cell 58 stem cell engraftment 58 IRX 2 58 CardioPass TM 58 bone marrow transplantations 58 afamelanotide 58 Intravenous CP 58 placebo controlled clinical 58 cellular immunotherapy 58 BRIM2 58 acetonide FA 58 Solazed 58 Ceflatonin R 57 Peptidomics 57 severe hypercholesterolemia 57 PLX cells 57 Biolimus A9 57 JAK2 inhibitor 57 EMPOWER ™ 57 SIR Spheres 57 Hepatocellular Carcinoma 57 inhibitor RG# 57 obatoclax 57 KL4 surfactant 57 cleavable linker 57 Relivar 57 TOCOSOL Camptothecin 57 bevacizumab Avastin 57 STRIDE PD 57 placenta derived 57 EP #R 57 oral PTH 57 relapsing remitting MS RRMS 57 Mimpara 57 dermaPACE TM 57 DCVax R Brain 57 immunomodulatory therapy 57 acute decompensated heart 57 anti infective treatments 57 phase IIa clinical 57 secondary hyperparathyroidism 57 BLA filing 57 PrevOnco ™ 57 torezolid phosphate 57 pharmacological chaperone 57 either acutely decompensated 57 ONCONASE R 57 novel antiviral therapeutics 57 CEQ# 57 autologous bone marrow 57 canakinumab 57 Phase III Clinical Trial 57 randomized Phase IIb 57 non nucleoside 57 cancer immunotherapies 57 APTIVUS 57 TORISEL 57 teriflunomide 57 CoFactor 57 Lisofylline 57 ZOLINZA 57 Neurostep TM 57 sodium thiosulfate STS 57 Onalta ™ 57 thetreatment 57 BENLYSTA ® 57 vascular disrupting agents 57 rt PA 57 Pafuramidine 57 letrozole Femara 57 direct thrombin inhibitor 57 CYT# potent vascular disrupting 57 cangrelor 57 Degarelix 57 basal bolus regimen 57 BioSTAR R 57 pancreatic NET 57 elective PCI 57 Panzem R NCD 57 calcineurin inhibitor 57 delivers fluocinolone acetonide FA 57 Acute Ischemic Stroke 57 Vascugel 57 NV1FGF 57 malignant ascites 57 rhFVIIa 57 voclosporin 57 cystinosis patients 57 EVIZON TM 57 teduglutide 57 Vidofludimus 57 ISTODAX 57 Iluvien ® 57 Dasatinib 57 MAGE A3 ASCI 57 Symadex 57 Fabry Disease 57 Adnectin 57 MyVax ® 57 Quinamed 57 Deforolimus 57 CCR9 antagonist 57 Dalbavancin 57 TOCOSOL Paclitaxel 57 coronary intervention 57 Alinia 57 CLORETAZINE TM VNP#M 57 autologous SCT 57 Acute Decompensated Heart Failure 57 Solazed TM 57 Loramyc R 57 Campath ® 57 SERCA2a 57 NAVISTAR R 57 Phase III randomized controlled 57 ADP receptor antagonist 57 PEGylated 57 clinical trial 57 Phase 2a clinical trials 57 Tyrima 57 solithromycin 57 Hepatocellular Carcinoma HCC 57 Vivaglobin 57 CR# vcMMAE 57 PREOS 57 eniluracil 57 Tarceva TM 57 Safinamide 57 TTF Therapy 57 AA amyloidosis 57 catheter occlusion 57 Zavesca R 57 hematological malignancy 57 Natalizumab 57 bardoxolone methyl 57 thrombolytic agent 57 lupus nephritis 57 lenalidomide Revlimid R 57 Bendamustine 57 AEG# 57 iron chelation 57 omacetaxine mepesuccinate 57 EndoTAG TM 57 relapsed MM 57 docetaxel Taxotere R 57 CellCept mycophenolate mofetil 57 TBC# 57 JAK1 57 Fibrocaps 57 isavuconazole 57 Exelixis compounds 57 Feasibility Trial 57 Ozurdex 57 superficial bladder cancer 57 ALN PCS 57 Hizentra 57 Metastatic Melanoma 57 PROCHYMAL 57 Omacetaxine 57 delafloxacin 57 Cyclosporin 57 Plicera 57 haematological malignancies 57 IIa trial 57 registrational trial 57 metastatic malignant 57 oral anticoagulant 57 C1INH 57 Zemiva TM 57 dirucotide MBP# 57 eculizumab therapy 57 #D#C# 57 PROMACTA 57 Pyridorin 57 Alessandro Riva 57 Plasmin 57 CMV vaccine 57 BST CarGel R 57 molecular imaging radiopharmaceutical 57 Zelrix 57 Advagraf 57 selective androgen receptor modulator 57 hA# 57 Phase 1a clinical 57 Cerashield 57 OvaRex ® MAb 57 DDP# 57 IMC #B 57 phase IIa 57 vemurafenib 57 NO# [002] 57 Vidaza azacitidine 57 Onalta 57 NEUMUNE 57 rituximab Rituxan 57 CA4P 56 Panzem ® 56 grade glioma 56 Perforomist ™ Inhalation Solution 56 fosbretabulin 56 IMiDs ® compound 56 Zilver PTX 56 GALNS 56 rxRNA 56 Removab 56 IMiDs ® 56 hypoparathyroidism 56 Tamibarotene 56 ProSavin 56 custirsen 56 axitinib 56 dexpramipexole 56 paclitaxel poliglumex 56 PDX pralatrexate 56 leading oral taxane 56 omega interferon 56 autologous hematopoietic stem cell 56 induced macular edema 56 Virulizin R 56 Achieves Primary Endpoint 56 herpetic keratitis 56 Certican 56 sunitinib 56 Phase #/#a trial 56 ACZ# 56 tafamidis 56 multicenter clinical trials 56 bioengineered tissue 56 anticancer therapies 56 Excellagen 56 tivozanib 56 ExCell study 56 Golimumab 56 cilengitide 56 Lenalidomide 56 Zerenex 56 liver resection 56 intra arterial chemotherapy 56 haematological cancers 56 Neulasta R 56 immunotherapeutic agent 56 Neo Bladder Augment 56 RECOTHROM ® 56 Aplidin R 56 HuCNS SC ® 56 recombinant tissue plasminogen 56 Claes Glassell president 56 Peginterferon alfa 2b 56 Octreolin 56 CytoFab 56 Spiegelmer ® 56 CMV reactivation 56 TREDAPTIVE 56 ADVANCE PD 56 DPP4 inhibitor 56 DIABECELL 56 multicenter Phase II 56 Periowave TM Photodisinfection System 56 post surgical adhesions 56 investigational humanized monoclonal antibody 56 Provacel 56 investigational therapies 56 double blinded randomized 56 CMV disease 56 romiplostim 56 dose escalation Phase 56 thrombolytic agents 56 LCP Tacro 56 diarrhea predominant irritable 56 Eluting Stent 56 TYZEKA 56 CCR5 antagonist 56 BIO SET 56 Vivecon 56 oral salmon calcitonin 56 tiapamil 56 Omigard 56 Menerba 56 MEK inhibitors 56 IL# PE#QQR 56 NP2 Enkephalin 56 galiximab 56 hypervascular tumors 56 hyperphenylalaninemia HPA due 56 Fibrillex 56 myelofibrosis 56 ORENCIA R 56 recurrent ovarian cancer 56 VEGF inhibitors 56 Exherin TM 56 Q#IR 56 ancrod 56 Stimuvax R 56 TELINTRA 56 EDEMA3 56 chronic myocardial ischemia 56 ER CHOP 56 YONDELIS R 56 recombinant enzyme 56 liposomal amphotericin B 56 Chronic Heart Failure 56 vinca alkaloid 56 tolevamer 56 adipose derived stem cell 56 Epratuzumab 56 MyoCell TM 56 TKM PLK1 56 humanized antibody 56 clevudine 56 Thalomid ® 56 intra abdominal abscess 56 zanolimumab 56 convenient dosing regimens 56 SUCCEED trial 56 CINtec R 56 phase IIb III 56 Deferiprone 56 mixed hyperlipidemia 56 Asentar 56 antithrombotic therapy 56 dose melphalan 56 maribavir 56 HeartNet 56 DermTech International 56 EOquin 56 CCR5 inhibitor 56 recombinant interferon 56 Genz # 56 Celution System 56 COMFORT II 56 Immunotherapeutic 56 Squalamine 56 predictive biomarkers 56 Alzhemed TM 56 Phase Ib clinical 56 EndoTAG TM -1 56 prospective multicenter study 56 Diabetic Macular Edema 56 Mozobil 56 Insulin detemir 56 regenerative therapy 56 antitumor effect 56 HER2 overexpression 56 CIMZIA TM 56 urothelial cancer 56 KL4 Surfactant 56 entinostat 56 immatics 56 HGS ETR2 56 AQ4N 56 vorinostat 56 HepaGam B TM 56 cutaneous T 56 Campath alemtuzumab 56 keloid scarring 56 calcitonin 56 BHT DNA 56 HuCNS SC 56 Factor Xa inhibitor 56 cell lymphoma CTCL 56 plasmid DNA vaccine 56 KNS # 56 relapsing multiple sclerosis 56 Aryplase 56 antiplatelet therapies 56 Soliris TM eculizumab 56 Cannabinor 56 drug eluting coronary stent 56 pan HDAC inhibitor 56 SAR# [004] 56 TRV# [001] 56 TMC# [002] 56 tubulin inhibitor 56 AzaSite Plus 56 DiabeCell ® 56 myoblast therapy 56 evaluating tivozanib 56 candidates Azedra TM 56 Dacogen decitabine 56 TKM ApoB 56 Zenvia ™ 56 Lodotra TM 56 pathogen inactivation 56 standard chemotherapy regimens 56 Cimzia TM 56 investigational antiplatelet agent 56 unresectable tumors 56 Phase 2a trial 56 intravenous methylnaltrexone 56 Trimesta 56 GRN# 56 Platinol ® cisplatin 56 myelodysplastic syndromes MDS 56 Romiplostim 56 Phase IIb III 56 Vidaza R 56 Behcet uveitis 55 mycophenolate mofetil 55 Host Disease GvHD 55 Vernakalant 55 isoform selective 55 Tolvaptan 55 triphendiol 55 intranasal insulin 55 FavId 55 RGB # 55 Entereg R 55 refractory acute myeloid 55 Potelligent Technology 55 LBH# 55 intravenous cyclophosphamide 55 Azacitidine 55 levodopa carbidopa 55 Gleevec imatinib mesylate 55 oral taxane 55 MOZOBIL 55 Cloretazine R VNP#M 55 aleglitazar 55 Yondelis ® 55 acute GvHD 55 ARIKACE ™ 55 punctal plug drug 55 allogeneic hematopoietic cell 55 ASPIRE HIGHER 55 hypereosinophilic syndrome 55 IIb clinical trial 55 personalized cellular immunotherapy 55 DCVax Brain 55 Phase III clinical 55 TroVax ® 55 JZP 55 nucleotide analogue 55 orally bioavailable 55 RE LY 55 de novo kidney transplant 55 Hydroxyurea 55 Annamycin 55 IMiDs R 55 Octreotide 55 CardioFit 55 Artelon ® 55 MIST II 55 ascending dose 55 lapatinib Tykerb 55 Angiox R 55 dextofisopam 55 Herceptin trastuzumab 55 Liprotamase 55 recurrent NSCLC 55 Prodarsan 55 Torisel 55 STEEN Solution ™ 55 Lymphoseek ® 55 Levulan PDT 55 midstage trials 55 MelaFind R 55 Ceflatonin 55 GED aPC 55 IIa trials 55 bioabsorbable stent 55 ABSORB clinical 55 GAMMAGARD 55 RhuDex ® 55 chronic eosinophilic leukemia 55 CytoFab ™ 55 placebo controlled randomized 55 paclitaxel Taxol ® 55 Friedreich Ataxia FRDA 55 CRLX# 55 blinded randomized 55 phosphate binder 55 TELCYTA 55 Azedra TM 55 lintuzumab 55 proliferative retinopathy 55 osteoinductive 55 Pazopanib 55 Glybera R 55 ProCord 55 lyophilized formulation 55 rBChE 55 zoledronic acid Zometa 55 aHUS 55 lymphoid tumors 55 eculizumab 55 Facet Solutions 55 Selective Electrochemical Tumor Ablation 55 bortezomib Velcade 55 stem cell transplantations 55 sJIA 55 NSABP C 55 myoblast 55 oral antidiabetic medication 55 enzastaurin 55 immune globulins 55 AZX# 55 PEGylated anti 55 Fodosine 55 renal transplantation 55 Desmoteplase 55 DuraHeart 55 Zalypsis 55 lucinactant 55 opioid induced bowel dysfunction 55 Novolimus 55 RezularTM 55 tezampanel NGX# 55 ADAMTS# 55 GRNCM1 55 Fibrillex TM 55 Tracleer R 55 SPRYCEL ® 55 hepatitis C HCV 55 Corus CAD 55 renin inhibitors 55 APEX PD 55 biliary tract cancer 55 monoclonal antibody therapeutics 55 alfa interferon 55 BRIM3 55 ISF# 55 CMV seropositive 55 confirmatory Phase III 55 HCD# [002] 55 TheraCIM 55 Valsartan 55 Anthim 55 biosurgical 55 TQT studies 55 recombinant factor VIIa 55 Curaxin CBLC# 55 recurrent glioblastoma multiforme 55 Voraxaze ™ 55 GI motility disorders 55 oral FTY# 55 successfully commercialize Iluvien 55 urethral bulking agent 55 double blinded placebo 55 preclinical efficacy 55 carotid artery stent 55 Cellegesic 55 Helixate FS 55 recombinant biopharmaceutical 55 cell transplantation 55 anticancer therapy 55 Liprostin 55 Thrombin 55 REG1 55 paclitaxel eluting stents 55 cardio renal 55 COREG CR 55 Phase IIb trial 55 Genasense ® 55 DXL TM 55 INTERCEPT red 55 Drug Eluting Stent System 55 anti angiogenic agents 55 iniparib 55 bladder augmentation 55 Vimpat ® lacosamide 55 eltrombopag 55 Pivotal Phase III 55 eprotirome 55 recombinant PSMA vaccine 55 targeted antifolate 55 panitumumab Vectibix 55 Daclizumab 55 dalbavancin 55 Electronic Brachytherapy 55 multicenter randomized placebo controlled 55 cGMP manufacture 55 multicenter prospective 55 recurrent glioblastoma 55 nucleotide analog 55 Tarvacin TM 55 Diamyd ® 55 PROSTASCINT R 55 GIPET 55 anti EGFR antibody 55 Progenta TM 55 Gleevec resistant 55 diagnostic modality 55 Azilect ® 55 Poly ICLC 55 Allogeneic 55 farletuzumab 55 ASONEP 55 postoperative ileus POI 55 L asparaginase 55 Sipuleucel T 55 AeroLEF TM 55 budesonide MMX Phase III 55 Traficet EN 55 DEFLUX 55 PEARL SC 55 irinotecan chemotherapy 55 Phase 1b trial 55 teplizumab 55 Kosan dependence 55 familial hypercholesterolemia FH 55 fibrotic disease 55 LUX Lung 55 vivo validation 55 Tanespimycin 55 BioNumerik 55 Tr DNA 55 Pivotal Phase 55 Oxaliplatin 55 oral iron chelator 55 Vaxfectin TM 55 SUTENT 55 WinRho R SDF 55 pralatrexate 55 adult mesenchymal stem 55 octreotide 55 BETAS 55 cetrorelix 55 relapsed ovarian cancer 55 NTx TM -# 55 Aganocide 55 GLPG# 55 Rasagiline 55 chemotherapy cisplatin 55 Onrigin TM 55 talactoferrin 55 carotid artery stenting 55 ponatinib 55 cinacalcet 55 hepatocellular carcinoma 55 Cell Lymphoma CTCL 55 autologous adult 55 Alfacell proprietary ribonuclease 55 Liver transplantation 55 PLX PAD 55 clinical pharmacology studies 55 TEMODAL 55 Rutherford Procedure 55 opioid analgesia 55 pomalidomide 55 doxercalciferol 55 bioartificial liver device 55 rFVIIa 55 hormone agonist 55 adult chronic ITP 55 HuCNS SC cells 55 fluvastatin 55 bone marrow stem cell 55 NAGS deficiency 55 pivotal bioequivalence 55 Bicifadine 55 IIa clinical trials 55 AP# [003] 55 amrubicin 55 Zolinza 55 efalizumab 55 lupus renal disease 55 VTE prophylaxis 55 Evoltra TM 55 oncolytic virus 55 paroxysmal nocturnal hemoglobinuria 55 Aflibercept 55 PrevOnco 55 OncoVex 55 Alfimeprase 55 rhIGF-I/rhIGFBP-3 55 Cellcept 55 JAK inhibitors 55 assessing T DM1 55 synthetic retinoid 55 dose escalation trial 55 Cardio Vascu Grow 55 MET amplification 55 evaluating REVLIMID 55 LymphoStat B TM 55 everolimus eluting stent 55 visilizumab 55 Capsule endoscopy 55 Interferon alpha 55 injectable formulation 55 polyclonal antibody 55 SCIg 55 trastuzumab Herceptin 55 clinical trials 55 intranasal formulation 55 retroviral vectors 55 Nanobody 55 pafuramidine 55 XmAb 55 DAPT 55 Gliadel Wafer 55 ALN TTR 55 Raptiva R 55 Vitaxin 55 NeuroFlo 55 autologous transplants 55 Veronate